Literature DB >> 14681938

Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.

Aylin Simsir1, Sonya Hwang, Joan Cangiarella, Paul Elgert, Pascale Levine, Matthew V Sheffield, Janie Roberson, Lynya Talley, David C Chhieng.   

Abstract

BACKGROUND: The 2001 Bethesda System recommended qualification of atypical glandular cells (AGC) to indicate the site of origin and separated endocervical adenocarcinoma in situ (AIS) from "AGC favor neoplastic" as a specific diagnostic category. To the authors' knowledge, the literature evaluating the reproducibility of Papanicolaou (Pap) smear diagnosis of glandular cell abnormalities with emphasis on the cell of origin is limited. The aim of the current study was to investigate whether a variety of benign to neoplastic glandular lesions can be reliably classified on Pap smear with regard to diagnosis and cell of origin.
METHODS: Twenty-three conventional Pap smears (CPS) with glandular cellular changes varying from benign to adenocarcinoma (ACA) were reviewed by six observers. They were asked to categorize each smear according to cell of origin (endocervical vs. endometrial) and diagnosis (benign, AGC, or ACA). Kappa statistics were used to evaluate interobserver agreement and correlation of interobserver agreement with experience.
RESULTS: There was no consensus among observers for both the origin of the cells and the diagnosis. Interobserver agreement for site was poor (kappa < 0.4) especially in the AGC category. Unanimous agreement for site was reached for 7 of 23 smears (30%). Two of five endocervical AIS were classified as endometrial and another two were classified as benign by four observers. Interobserver agreement was poor in all diagnostic categories (kappa < 0.4) and showed slight correlation with level of experience. Unanimous agreement for diagnosis was reached for only 2 smears (9%). Three of 11 (27%) smears demonstrating preneoplastic/neoplastic processes were diagnosed as benign by 3 observers. Three (25%) benign CPS were diagnosed as ACA by 2 observers. Accurate prediction of the final histologic diagnosis by observers varied from 30% to 87% and did not correlate closely with experience.
CONCLUSIONS: Cytologic diagnosis of glandular lesions by CPS was problematic and suffered from significant interobserver subjectivity. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 14681938     DOI: 10.1002/cncr.11826

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  Atypical endometrial cells and atypical glandular cells favor endometrial origin in Papanicolaou cervicovaginal tests: Correlation with histologic follow-up and abnormal clinical presentations.

Authors:  Longwen Chen; Christine N Booth; Julie A Shorie; Jennifer A Brainard; Matthew A Zarka
Journal:  Cytojournal       Date:  2014-11-14       Impact factor: 2.091

3.  Detecting uterine glandular lesions: Role of cervical cytology.

Authors:  Baneet Bansal; Parikshaa Gupta; Nalini Gupta; Arvind Rajwanshi; Vanita Suri
Journal:  Cytojournal       Date:  2016-02-22       Impact factor: 2.091

4.  Endometriosis mimicking glandular atypia in a cervical cytology.

Authors:  Paula A Rodriguez-Urrego; Isabel C Dulcey-Hormiga; Luis E Barrera-Herrera; David A Suarez-Zamora; Mauricio A Palau-Lazaro; Catalina Buritica-Cifuentes
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

5.  Atypical glandular cells in conventional cervical smears: incidence and follow-up.

Authors:  René Scheiden; Catherine Wagener; Ulrich Knolle; Walter Dippel; Catherine Capesius
Journal:  BMC Cancer       Date:  2004-07-19       Impact factor: 4.430

6.  Management of borderline change in endocervical cells: a more dependable approach.

Authors:  S Kodiathodi; S Chattopadhyay; A Baldwin; P Franks
Journal:  Br J Cancer       Date:  2014-06-26       Impact factor: 7.640

7.  Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.

Authors:  Fengxiang Xie; Liran Zhang; Dongman Zhao; Xuefen Wu; Mingsong Wei; Xuelian Zhang; Xiaohui Wu; Hao Fang; Xue Xu; Meng Yang; Debo Qi
Journal:  BMC Infect Dis       Date:  2019-11-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.